1990
DOI: 10.1016/0278-6915(90)90152-d
|View full text |Cite
|
Sign up to set email alerts
|

Structure-specificity of the genotoxicity of some naturally occurring alkenylbenzenes determined by the unscheduled DNA synthesis assay in rat hepatocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
52
0

Year Published

1992
1992
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(54 citation statements)
references
References 21 publications
2
52
0
Order By: Relevance
“…Methyleugenol gave a negative response in the Ames test and a mouse micronucleus assay, although a positive response has been reported in an in vitro unscheduled DNA synthesis (UDS) assay (35). It has been suggested that a lack of activity of alkenylbenzenes in the Ames test is most likely to be due to the failure of metabolic activation (35). Methyleugenol has also been reported to induce hepatic tumors in male mice treated prior to weaning (36).…”
Section: Resultsmentioning
confidence: 99%
“…Methyleugenol gave a negative response in the Ames test and a mouse micronucleus assay, although a positive response has been reported in an in vitro unscheduled DNA synthesis (UDS) assay (35). It has been suggested that a lack of activity of alkenylbenzenes in the Ames test is most likely to be due to the failure of metabolic activation (35). Methyleugenol has also been reported to induce hepatic tumors in male mice treated prior to weaning (36).…”
Section: Resultsmentioning
confidence: 99%
“…It has been demonstrated that a-asarone possess hypocholesterolemic [2,3,4] and hypolipidemic properties [3] due to the inhibition of HMG-CoA reductase [4], however a-asarone cannot be used in clinical trials due to its genotoxic and hepatocarcinogenic properties in rodents [5,6]. On the contrary, TMC, the major metabolite of a-asarone, does not have the above mentioned toxicological effects [6].…”
Section: Discussionmentioning
confidence: 99%
“…These findings could explain the hypocholesterolemic and the cholelitholytic properties of a-asarone. It has also been demonstrated that a-asarone possess genotoxic [5,6] and hepatocarcinogenic properties in rodents [7]. Therefore, a-asarone cannot be used in clinical trials.…”
Section: Introductionmentioning
confidence: 99%
“…Safrole was shown to increase UDS in primary rat hepatocytes and HeLa cells at concentrations of 0.000 162-1620 μg/ml (Michalopoulos et al, 1978;Althaus et al, 1982;Williams, 1984;Barrett, 1985;Glauert et al, 1985;Martin & Campbell, 1985;Williams et al, 1985;Howes et al, 1990b). It should be noted that at concentrations greater than 162 μg/ml, safrole is highly cytotoxic (Burkey et al, 2000).…”
Section: Mitotic Recombinationmentioning
confidence: 99%